BOCCADORO, Mario
BOCCADORO, Mario
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA.
2010-01-01 Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M
A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients
2010-01-01 Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Mosca Siez ML; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M
A PHASE III STUDY OF ENOXAPARIN VS ASPIRIN AS THROMBOPROPHYLAXIS FOR PATIENTS WITH NEWLY DIAGNOSED OF MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE-BASED REGIMENS.
2011-01-01 F. CAVALLO; T. CARAVITA; F. DI RAIMONDO; G. CICCONE; B. LUPO; M. MARCATTI; A. BARALDI; N. PESCOSTA; A.P. FALCONE ;R. RIA; L. BALDINI; L. MASINI; T. GUGLIELMELLI; G. GAIDANO; G. BENEVOLO; C. CANGIALOSI ; M. GALLI ; L. CATALANO; A. LAROCCA; A. NAGLER; M. BOCCADORO; A. PALUMBO
A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS
2014-01-01 Dario Ferrero; Elena Crisà; Filippo Marmont; Ernesta Audisio; Chiara Frairia; Valentina Giai; Tiziana Gatti; Moreno Festuccia; Benedetto Bruno; Ludovica Riera; Roberto Passera; Mario Boccadoro
A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo.
2007-01-01 B. Bruno; M. Rotta; F. Patriarca; D. Mattei; B. Allione; F. Carnevale-Schianca; A. Rambaldi; M. Casini; V. Montefusco; M. Parma; P. Bavaro; F. Onida; A. Busca; L. Castagna; M.P. Iori; D. Maloney; B. Sandmaier; F. Benedetti; N. Mordini; L. Giaccone; R. Sorasio; F. Fiore; A. Filippi; A. Palumbo; M. Aglietta; A. Levis; R. Foà; P. Di Bartolomeo; E. Pogliani; G. Lambertenghi-Deliliers; M. Falda; M. Petrini; P. Corradini; R. Fanin; U. Ricardi; R. Storb; I. Baldi; and Mario Boccadoro
A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL
2007-01-01 Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M
A PROSPECTIVE RANDOMIZED TRIAL OF BORTEZOMIB-MELPHALANPREDNISONE-THALIDOMIDE FOLLOWED BY CONTINUOUS BORTEZOMIB-THALIDOMIDE FOR INITIAL THERAPY OF MULTIPLE MYELOMA:EFFECT OF AGE AND CO-MORBIDITIES
2010-01-01 A Palumbo; S Bringhen; D Rossi; M Cavalli; R Ria; M Offidani; C Nozzoli; L Baldini; L De Rosa; G De Sabbata; AM Liberati; C Crippa; F Ciambelli; V Callea; M Spriano; F Ferrara; F Elice; M Galli; J Peccatori; L Catalano; M Rizzo; R Marasca; F Pisani; M Cavo; M Petrucci; P Musto; P Omedè; A Larocca; G Gaidano; M Boccadoro
A Prospective Randomized Trial of Oral Melphalan, Prednisone, Thalidomide (MPT) vs Oral Melphalan, Prednisone (MP): An Interim Analysis.
2004-01-01 Palumbo A; Bertola A; Musto P; Caravita T; Callea V; Cangialosi C; Liberati AM; Niscola P; Catalano L; Grasso M; Lauta VM; Petti MC; Morandi S; Galli S; Bringhen S; Cavallo F; Falco P; Boccadoro M
A Prospective, Randomized, Phase III Study of Enoxaparin Versus Aspirin Versus Low-Fixed-Dose of Warfarin in Newly Diagnosed Myeloma Patients Treated with Thalidomide-Containing Regimens.
2007-01-01 Palumbo A; Cavo M; Bringhen S; Perrone G; Magarotto V; Patriarca F; Petrucci MT; Galli M; Di Raimondo F; Rossi D; Marasca R; Offidani M; Goldaniga M; Corradini P; Crippa C; Catalano L; Callea V; Gozzini A; Tosi P; Boccadoro M
A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients.
2007-01-01 Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M
A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib.
2012-01-01 Dario Ferrero; Elena Crisà; Marco Cerrano; Mario Boccadoro; Francesca Pirillo; Maura Nicolosi; Umberto Vitolo; Giovanna Rege Cambrin; Carmen Fava; Giuseppe Saglio; Monia Lunghi; Gioacchino Catania; Alessandro Levis; and Patrizia Pregno.
A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience.
2012-01-01 Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P.
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients
2013-01-01 Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells
2019-01-01 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS
2010-01-01 F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo
Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: A Study from the Italian Bone Marrow Transplantation Donor Registry
2011-01-01 Benedetto Bruno; Roberto Passera; Francesca Patriarca; Francesca Bonifazi; Vittorio Montefusco; Michele Falda; Luisa Giaccone; Mauro Montanari; Andrea Bacigalupo; Stefano Guidi; Nicola Mordini; Alessandro Rambaldi; Giuseppe Milone; Angelo Michele Carella; Pasqua Bavaro; Fabio Ciceri; Rosanna Scimè; Eduardo Benedetti; Alessandro Levis; Paola Marenco; Marco Casini; Alberto Bosi; Paolo Corradini; Giuseppe Bandini; Renato Fanin; Mario Boccadoro; and Simona Pollichieni
Allografting from unrelated donors in multiple myeloma: a study by the Italian bone marrow donor registry
2012-01-01 Bruno B; Passera R; Patriarca F; Bonifazi F; Montefusco V; Falda M; Giaccone L; Montanari M; Bacigalupo A; Guidi S; Mordini N; Rambaldi A; Milone G; Carella AM; Bavaro P; Ciceri F; Scime R; Benedetti E; Levis A; Marenco P; Casini M; Bosi A; Corradini P; Bandini G; Fanin R; Pollichieni S; Boccadoro M
Allografting in relapsed/refractory Hodgkin's lymphoma, a single-centre experience
2012-01-01 Festuccia M; Passera R; Giaccone L; Locatelli F; Busca A; D'Ardia S; Allione B; Boccadoro M; Vitolo U; Falda M; Bruno B
An Update of a Comparison of Nonmyeloablative Allografting with Autografting for Newly Diagnosed Myeloma.
2007-01-01 B. Bruno; R. Sorasio; F. Patriarca; N. Mordini; B. Allione; F. Carnevale-Schianca; L. Giaccone; M. Rotta; P. Omedè; I. Baldi; S. Bringhen; M. Massaia; M. Aglietta; A. Levis; D. Mattei; R. Fanin; A. Palumbo; R. Storb; G. Ciccone; and Mario Boccadoro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA. | 2010 | Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M | |
| A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients | 2010 | Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Mosca Siez ML; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M | |
| A PHASE III STUDY OF ENOXAPARIN VS ASPIRIN AS THROMBOPROPHYLAXIS FOR PATIENTS WITH NEWLY DIAGNOSED OF MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE-BASED REGIMENS. | 2011 | F. CAVALLO; T. CARAVITA; F. DI RAIMONDO; G. CICCONE; B. LUPO; M. MARCATTI; A. BARALDI; N. PESCOSTA; A.P. FALCONE ;R. RIA; L. BALDINI; L. MASINI; T. GUGLIELMELLI; G. GAIDANO; G. BENEVOLO; C. CANGIALOSI ; M. GALLI ; L. CATALANO; A. LAROCCA; A. NAGLER; M. BOCCADORO; A. PALUMBO | |
| A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS | 2014 | Dario Ferrero; Elena Crisà; Filippo Marmont; Ernesta Audisio; Chiara Frairia; Valentina Giai; Tiziana Gatti; Moreno Festuccia; Benedetto Bruno; Ludovica Riera; Roberto Passera; Mario Boccadoro | |
| A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo. | 2007 | B. Bruno; M. Rotta; F. Patriarca; D. Mattei; B. Allione; F. Carnevale-Schianca; A. Rambaldi; M. Casini; V. Montefusco; M. Parma; P. Bavaro; F. Onida; A. Busca; L. Castagna; M.P. Iori; D. Maloney; B. Sandmaier; F. Benedetti; N. Mordini; L. Giaccone; R. Sorasio; F. Fiore; A. Filippi; A. Palumbo; M. Aglietta; A. Levis; R. Foà; P. Di Bartolomeo; E. Pogliani; G. Lambertenghi-Deliliers; M. Falda; M. Petrini; P. Corradini; R. Fanin; U. Ricardi; R. Storb; I. Baldi; and Mario Boccadoro | |
| A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL | 2007 | Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M | |
| A PROSPECTIVE RANDOMIZED TRIAL OF BORTEZOMIB-MELPHALANPREDNISONE-THALIDOMIDE FOLLOWED BY CONTINUOUS BORTEZOMIB-THALIDOMIDE FOR INITIAL THERAPY OF MULTIPLE MYELOMA:EFFECT OF AGE AND CO-MORBIDITIES | 2010 | A Palumbo; S Bringhen; D Rossi; M Cavalli; R Ria; M Offidani; C Nozzoli; L Baldini; L De Rosa; G De Sabbata; AM Liberati; C Crippa; F Ciambelli; V Callea; M Spriano; F Ferrara; F Elice; M Galli; J Peccatori; L Catalano; M Rizzo; R Marasca; F Pisani; M Cavo; M Petrucci; P Musto; P Omedè; A Larocca; G Gaidano; M Boccadoro | |
| A Prospective Randomized Trial of Oral Melphalan, Prednisone, Thalidomide (MPT) vs Oral Melphalan, Prednisone (MP): An Interim Analysis. | 2004 | Palumbo A; Bertola A; Musto P; Caravita T; Callea V; Cangialosi C; Liberati AM; Niscola P; Catalano L; Grasso M; Lauta VM; Petti MC; Morandi S; Galli S; Bringhen S; Cavallo F; Falco P; Boccadoro M | |
| A Prospective, Randomized, Phase III Study of Enoxaparin Versus Aspirin Versus Low-Fixed-Dose of Warfarin in Newly Diagnosed Myeloma Patients Treated with Thalidomide-Containing Regimens. | 2007 | Palumbo A; Cavo M; Bringhen S; Perrone G; Magarotto V; Patriarca F; Petrucci MT; Galli M; Di Raimondo F; Rossi D; Marasca R; Offidani M; Goldaniga M; Corradini P; Crippa C; Catalano L; Callea V; Gozzini A; Tosi P; Boccadoro M | |
| A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients. | 2007 | Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M | |
| A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib. | 2012 | Dario Ferrero; Elena Crisà; Marco Cerrano; Mario Boccadoro; Francesca Pirillo; Maura Nicolosi; Umberto Vitolo; Giovanna Rege Cambrin; Carmen Fava; Giuseppe Saglio; Monia Lunghi; Gioacchino Catania; Alessandro Levis; and Patrizia Pregno. | |
| A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience. | 2012 | Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P. | |
| A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients | 2013 | Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A | |
| Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS | 2010 | F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo | |
| Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: A Study from the Italian Bone Marrow Transplantation Donor Registry | 2011 | Benedetto Bruno; Roberto Passera; Francesca Patriarca; Francesca Bonifazi; Vittorio Montefusco; Michele Falda; Luisa Giaccone; Mauro Montanari; Andrea Bacigalupo; Stefano Guidi; Nicola Mordini; Alessandro Rambaldi; Giuseppe Milone; Angelo Michele Carella; Pasqua Bavaro; Fabio Ciceri; Rosanna Scimè; Eduardo Benedetti; Alessandro Levis; Paola Marenco; Marco Casini; Alberto Bosi; Paolo Corradini; Giuseppe Bandini; Renato Fanin; Mario Boccadoro; and Simona Pollichieni | |
| Allografting from unrelated donors in multiple myeloma: a study by the Italian bone marrow donor registry | 2012 | Bruno B; Passera R; Patriarca F; Bonifazi F; Montefusco V; Falda M; Giaccone L; Montanari M; Bacigalupo A; Guidi S; Mordini N; Rambaldi A; Milone G; Carella AM; Bavaro P; Ciceri F; Scime R; Benedetti E; Levis A; Marenco P; Casini M; Bosi A; Corradini P; Bandini G; Fanin R; Pollichieni S; Boccadoro M | |
| Allografting in relapsed/refractory Hodgkin's lymphoma, a single-centre experience | 2012 | Festuccia M; Passera R; Giaccone L; Locatelli F; Busca A; D'Ardia S; Allione B; Boccadoro M; Vitolo U; Falda M; Bruno B | |
| An Update of a Comparison of Nonmyeloablative Allografting with Autografting for Newly Diagnosed Myeloma. | 2007 | B. Bruno; R. Sorasio; F. Patriarca; N. Mordini; B. Allione; F. Carnevale-Schianca; L. Giaccone; M. Rotta; P. Omedè; I. Baldi; S. Bringhen; M. Massaia; M. Aglietta; A. Levis; D. Mattei; R. Fanin; A. Palumbo; R. Storb; G. Ciccone; and Mario Boccadoro |